{"nct_id":"NCT04541706","title":"Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2020-08-27","start_date_type":"ACTUAL","primary_completion_date":"2022-07-20","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-20","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["PFE"]}